Remission and progression of pre-existing micro- and macroalbuminuria over 15 years after bariatric surgery in Swedish Obese Subjects study
- 7 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Obesity
- Vol. 45 (3), 535-546
- https://doi.org/10.1038/s41366-020-00707-z
Abstract
Background Bariatric surgery reduces incidence of albuminuria and end-stage renal disease in patients with obesity. Effects of bariatric surgery on long-term remission and progression of pre-existing obesity-related renal damage are mainly unexplored. Here we investigate the long-term effects of bariatric surgery compared with conventional obesity care on remission and progression of albuminuria. Methods 4047 patients were included in the Swedish Obese Subjects study. Inclusion criteria were age 37–60 years, BMI ≥ 34 kg/m2 in men and BMI ≥ 38 kg/m2 in women. Our analysis comprised 803 patients (19.8% of total population, 357 control, 446 surgery) with pre-existing albuminuria including 693 patients (312 control, 381 surgery) with microalbuminuria, and 110 patients (45 control, 65 surgery) with macroalbuminuria. Surgery patients were treated with banding, vertical banded gastroplasty, or gastric bypass. Control patients received conventional obesity care. Results Total urinary albumin excretion was 36.5% lower in all patients with albuminuria after 15 years, 44.5% lower in patients with microalbuminuria after 15 years, and 27.8% lower in patients with macroalbuminuria after 2 years following bariatric surgery compared with conventional care. In surgery patients with microalbuminuria, remission to normoalbuminuria was higher (OR, 5.9, 2.2, 3.2, p < 0.001) and progression to macroalbuminuria was lower (OR, 0.28, 0.26, 0.25, p ≤ 0.02) at 2, 10, and 15 years, respectively, compared with control patients. In surgery patients with macroalbuminuria remission to normo- or microalbuminuria was higher (OR, 3.67, p = 0.003) after 2 years. No differences between surgery and control patients with macroalbuminuria were observed after 10 and 15 years. Surgery slowed progression of eGFR decline after 2 years in patients with microalbuminuria and macroalbuminuria (treatment effect: 1.0 ml/min/1.73 m2/year, p = 0.001 and 1.4 ml/min/1.73 m2/year, p = 0.047, respectively). Conclusion Bariatric surgery had better effects than conventional obesity care on remission of albuminuria and prevention of eGFR decline, indicating that patients with obesity-related renal damage benefit from bariatric surgery.This publication has 50 references indexed in Scilit:
- Effects of Bilio-Pancreatic Diversion on Diabetic ComplicationsDiabetes Care, 2011
- Scope and mechanisms of obesity-related renal diseaseCurrent Opinion in Nephrology and Hypertension, 2010
- Pathological influence of obesity on renal structural changes in chronic kidney diseaseClinical and Experimental Nephrology, 2009
- Low Cardiorespiratory Fitness Levels and Elevated Blood PressureHypertension, 2009
- The effect of weight loss after bariatric surgery on albuminuriaClinical Nephrology, 2008
- Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsThe New England Journal of Medicine, 2007
- Obesity induces a phenotypic switch in adipose tissue macrophage polarizationJCI Insight, 2007
- Statins Prevent Oxidized LDL-Induced Injury of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/AKT-Signaling PathwayJournal of the American Society of Nephrology, 2005
- Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone SecretionHypertension, 2004
- Tissue-specific nutritional regulation of angiotensinogen in adipose tissue.Hypertension, 1992